Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 501–600 of 1,020
Left Atrial Appendage: Physiology, Pathology, and Role as a Therapeutic Target
Regazzoli, D., Ancona, F., Trevisi, N. M., Guarracini, F., Radinovic, A., Oppizzi, M., Agricola, E., Marzi, A., Sora, N., Bella, P. E. D., et al. (2015) · BioMed Research International · doi:10.1155/2015/205013 · Cited by 105
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients
Ashburner, J. M., Go, A. S., Chang, Y., Fang, M. C., Fredman, L., Applebaum, K. M., & Singer, D. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.080 · Cited by 91
Chang, S., Dong, J., Ma, C., Du, X., Wu, J., Tang, R., Xia, S., Guo, X., Yu, R., Long, D., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.012988 · Cited by 105
Self-citationEchocardiographic Prediction of Pre- versus Postcapillary Pulmonary Hypertension
D’Alto, M., Romeo, E., Argiento, P., Pavelescu, A., Mélot, C., D’Andrea, A., Correra, A., Bossone, E., Calabrò, R., Russo, M. G., et al. (2014) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2014.09.004 · Cited by 105
Should Women Receive Left Ventricular Assist Device Support? Findings From INTERMACS
Hsich, E., Naftel, D. C., Myers, S. L., Gorodeski, E. Z., Grady, K. L., Schmuhl, D., Ulisney, K. L., & Young, J. B. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.963272 · Cited by 105
Quality of Anticoagulation With Vitamin K Antagonists
Bertomeu‐González, V., Anguita, M. P., Arribas, J. M., Cequier, A. R., Muñiz, J., Castillo‐Castillo, J., Sanchís, J. M., Roldán, I., Marín, F. R., Bertoméu, V., et al. (2015) · Clinical Cardiology · doi:10.1002/clc.22397 · Cited by 103
Okumura, Y., Yokoyama, K., Matsumoto, N., Tachibana, E., Kuronuma, K., Oiwa, K., Matsumoto, M., Kojima, T., Hanada, S., Nomoto, K., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2016.11.003 · Cited by 104
Ferreira, J., Ezekowitz, M. D., Connolly, S. J., Brueckmann, M., Fraessdorf, M., Reilly, P. A., Yusuf, S., & Wallentin, L. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft111 · Cited by 98
The application of Big Data in medicine: current implications and future directions
Austin, C. O., & Kusumoto, F. M. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0104-y · Cited by 103
New-Onset Atrial Fibrillation in Adult Patients After Cardiac Surgery
Burrage, P. S., Low, Y., Campbell, N. G. S., & O’Brien, B. (2019) · Current anesthesiology reports · doi:10.1007/s40140-019-00321-4 · Cited by 103
Kirchhof, P., Medicine, E. C. R. A. E. A. W. S. O. P., Sipido, K. R., Medicine, E. C. R. A. E. A. W. S. O. P., Cowie, M. R., Medicine, E. C. R. A. E. A. W. S. O. P., Eschenhagen, T., Medicine, E. C. R. A. E. A. W. S. O. P., Fox, K. A. A., Medicine, E. C. R. A. E. A. W. S. O. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu312 · Cited by 90
Walkey, A. J., Quinn, E. K., Winter, M. R., McManus, D. D., & Benjamin, E. J. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2181 · Cited by 102
Hulme, O. L., Khurshid, S., Weng, L.-C., Anderson, C. D., Wang, E. Y., Ashburner, J. M., Ko, D., McManus, D. D., Benjamin, E. J., Ellinor, P. T., et al. (2019) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2019.07.016 · Cited by 96
Vascular Disease and Stroke Risk in Atrial Fibrillation: A Nationwide Cohort Study
Olesen, J. B., Lip, G. Y. H., Lane, D. A., Køber, L., Hansen, M. L., Karasoy, D., Hansen, C. M., Gislason, G., & Torp-Pedersen, C. T. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.024 · Cited by 106
Self-citationAlbertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013) · Stroke · doi:10.1161/strokeaha.113.000883 · Cited by 101
Self-citationSteinberg, B. A., Greiner, M. A., Hammill, B. G., Curtis, L. H., Benjamin, E. J., Heckbert, S. R., & Piccini, J. P. (2015) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12129 · Cited by 102
Obesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
Asghar, O., Alam, U., Hayat, S. A., Aghamohammadzadeh, R., Heagerty, A. M., & Malik, R. A. (2012) · Current Cardiology Reviews · doi:10.2174/157340312803760749 · Cited by 101
Friberg, L., Engdahl, J., Frykman, V., Svennberg, E., Levin, L.-Å., & Rosenqvist, M. (2013) · EP Europace · doi:10.1093/europace/eus217 · Cited by 100
Poulsen, B. K., Grove, E. L., & Husted, S. (2012) · Drugs · doi:10.2165/11635730-000000000-00000 · Cited by 101
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
Roberti, R., Iannone, L. F., Palleria, C., Curcio, A., Rossi, M., Sciacqua, A., Armentaro, G., Vero, A., Manti, A., Cassano, V., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.684638 · Cited by 101
Kim, T., Yang, P., Kim, D., Yu, H. T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., & Lip, G. Y. H. (2017) · Stroke · doi:10.1161/strokeaha.117.018551 · Cited by 99
Self-citationAtrial fibrillation and cancer – An unexplored field in cardiovascular oncology
Chu, G. K. T., Versteeg, H. H., Verschoor, A. J., Trines, S. A. I. P., Hemels, M. E. W., Ay, C., Huisman, M. V., & Klok, F. A. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.03.005 · Cited by 99
Ball, J., Carrington, M. J., Wood, K. A., Stewart, S., & the SAFETY Investigators (2013) · PLoS ONE · doi:10.1371/journal.pone.0065795 · Cited by 98
Stroke in atrial fibrillation: Review of risk stratification and preventive therapy
Alshehri, A. (2019) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_99_18 · Cited by 98
Rassaf, T., Totzeck, M., Backs, J., Bokemeyer, C., Hallek, M. J., Hilfiker‐Kleiner, D., Hochhaus, A., Lüftner, D., Müller, O. J., Neudorf, U., et al. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01636-7 · Cited by 98
Arihiro, S., Todo, K., Koga, M., Furui, E., Kinoshita, N., Kimura, K., Yamagami, H., Terasaki, T., Yoshimura, S., Shiokawa, Y., et al. (2016) · International Journal of Stroke · doi:10.1177/1747493016632239 · Cited by 97
Saliba, W., Schliamser, J. E., Lavi, I., Barnett‐Griness, O., Gronich, N., & Rennert, G. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.02.001 · Cited by 97
Nasir, J. M., Pomeroy, W. C., Marler, A. T., Hann, M. C., Baykaner, T., Jones, R., Stoll, R., Hursey, K., Meadows, A., Walker, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.04.026 · Cited by 97
Hernandez, I., Zhang, Y., & Saba, S. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.092 · Cited by 97
Brambatti, M., Darius, H., Oldgren, J., Clemens, A., Noack, H., Brueckmann, M., Yusuf, S., Wallentin, L. C., Ezekowitz, M. D., Connolly, S. J., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.141 · Cited by 96
Noseworthy, P. A., Yao, X., Deshmukh, A. J., Van Houten, H., Sangaralingham, L. R., Siontis, K. C., Piccini, J. P., Asirvatham, S. J., Friedman, P. A., Packer, D. L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002597 · Cited by 87
Clinical and Imaging Predictors of Recurrent Ischemic Stroke: A Systematic Review and Meta-Analysis
Kauw, F., Takx, R. A. P., de Jong, H. W. A. M., Velthuis, B. K., Kappelle, L. J., & Dankbaar, J. W. (2018) · Cerebrovascular Diseases · doi:10.1159/000490422 · Cited by 89
Managing atrial fibrillation in the very elderly patient: challenges and solutions
Letsas, Κ. P., Karamichalakis, N., Vlachos, K. G., Georgopoulos, S., Bakalakos, A., Efremidis, M., & Sideris, A. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s83664 · Cited by 96
Chua, S., Lo, H., Chiu, C.-Z., & Shyu, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111167 · Cited by 97
Lip, G. Y. H., Ponikowski, P. P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., Morais, J., Pullicino, P. M., Rasmussen, L. H., Marín, F. R., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs073 · Cited by 97
Self-citationNew Oral Anticoagulants in Practice: Pharmacological and Practical Considerations
Wang, Y., & Bajorek, B. V. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0061-0 · Cited by 97
Lip, G. Y. H., Rushton-Smith, S. K., Goldhaber, S. Z., Fitzmaurice, D. A., Mantovani, L. G., Goto, S., Haas, S. K., Bassand, J., Camm, A. J., Ambrosio, G., et al. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001556 · Cited by 97
Self-citationAntithrombotic treatment in elderly patients with atrial fibrillation: a practical approach
on behalf of Grupo de trabajo de Riesgo vascular de la, S. E. M. I., Fernández, C. S., Formiga, F., Camafort, M., Rodrigo, J. M. C., Díez‐Manglano, J., Reino, A. P., Tiberio, G., & Mostaza, J. M. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0137-7 · Cited by 96
Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
Lee, S., Choi, E., Park, C. S., Han, K., Jung, J., Oh, S., & Lip, G. Y. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.051 · Cited by 95
Self-citationLoring, Z., Holmes, D. N., Matsouaka, R., Curtis, A. B., Day, J. D., Desai, N. R., Ellenbogen, K. A., Feld, G. K., Fonarow, G. C., Frankel, D. S., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007944 · Cited by 95
Görenek, B., Lundqvist, C. B., Brugada, J., Camm, A. J., Hindricks, G., Huber, K., Kirchhof, P. F., Kück, K., Kudaiberdieva, G., Lin, T., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m08_19 · Cited by 95
Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
Filho, A. M. L., Azmus, A., Soeiro, A., Quadros, A., Avezum, Á., Marques, A., Franci, A., Manica, A., Volschan, A., de Paola, A., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s009 · Cited by 99
Yao, X., Gersh, B. J., Sangaralingham, L. R., Kent, D. M., Shah, N. D., Abraham, N. S., & Noseworthy, P. A. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.051 · Cited by 96
Chao, T., Liu, C.-J., Wang, K.-L., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Chung, F., Liao, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.06.021 · Cited by 95
Self-citationAntithrombotic therapy for stroke prevention in non-valvular atrial fibrillation
Alberts, M. J., Eikelboom, J. W., & Hankey, G. J. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70258-2 · Cited by 97
Yoshida, K., Obokata, M., Kurosawa, K., Sorimachi, H., Kurabayashi, M., & Negishi, K. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.116.004999 · Cited by 94
Velangi, P. S., Choo, C., Chen, K.-H. A., Kazmirczak, F., Nijjar, P. S., Farzaneh‐Far, A., Okasha, O., Akçakaya, M., Weinsaft, J. W., & Shenoy, C. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.119.009723 · Cited by 94
Thromboprophylaxis for atrial arrhythmias in congenital heart disease: A multicenter study
Khairy, P., Aboulhosn, J., Broberg, C. S., Cohen, S. B., Cook, S. C., Dore, A., Fernandes, S. M., Fournier, A., Kay, J. D., Lévesque, S., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.223 · Cited by 94
Gattellari, M., Goumas, C., Aitken, R. J., & Worthington, J. M. (2011) · Cerebrovascular Diseases · doi:10.1159/000330637 · Cited by 93
Chew, D. S., Li, Z., Steinberg, B. A., O’Brien, E. C., Pritchard, J. E., Bunch, T. J., Mark, D. B., Patel, M. R., Nabutovsky, Y., Greiner, M. A., et al. (2022) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.121.010304 · Cited by 93
Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study
Fauchier, L., Clémenty, N., Pelade, C., Collignon, C., Nicolle, E., & Lip, G. Y. H. (2015) · Stroke · doi:10.1161/strokeaha.115.010270 · Cited by 94
Self-citationYamashita, Y., Hamatani, Y., Esato, M., Chun, Y., Tsuji, H., Wada, H., Hasegawa, K., Abe, M., Lip, G. Y. H., & Akao, M. (2015) · CHEST Journal · doi:10.1378/chest.15-1095 · Cited by 95
Self-citationMarzona, I., Proietti, M., Farcomeni, A., Romiti, G. F., Romanazzi, I., Raparelli, V., Basili, S., Lip, G. Y. H., Nobili, A., & Roncaglioni, M. C. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.07.044 · Cited by 93
Self-citationAronis, K. N., Zhao, D., Hoogeveen, R. C., Alonso, Á., Ballantyne, C. M., Güallar, E., Jones, S. R., Martin, S. S., Nazarian, S., Steffen, B. T., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007372 · Cited by 92
Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J., & Ferro, C. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.381 · Cited by 93
Self-citationJones, W. S., Hellkamp, A. S., Halperin, J., Piccini, J. P., Breithardt, G., Singer, D. E., Fox, K. A. A., Hankey, G. J., Mahaffey, K. W., Califf, R. M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht492 · Cited by 91
Fluckiger, J. U., Goldberger, J. J., Lee, D. C., Ng, J., Lee, R., Goyal, A., & Markl, M. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23994 · Cited by 92
Predictors of Atrial Fibrillation After Coronary Artery Bypass Grafting: A Bayesian Analysis
Perrier, S. L., Meyer, N., Minh, T. H., Announe, T., Bentz, J., Billaud, P., Mommerot, A., Mazzucotelli, J., & Kindo, M. J. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.05.115 · Cited by 92
for the ATRIUM investigators, Meinertz, T., Kirch, W., Rosin, L., Pittrow, D., Willich, S. N., & Kirchhof, P. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0320-5 · Cited by 91
“AF management therefore consists of antithrombotic therapy, which is guided by clinical stroke risk estimation [1, 21 ], rate control therapy to improve left ventricular function and symptoms during AF, and rhythm control therapy to prevent AF recurrences.”
MethodResultDzeshka, M. S., Shahid, F., Shantsila, A., & Lip, G. Y. H. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx013 · Cited by 91
Self-citationPeterson, E. D., Ashton, V., Chen, Y.-W., Wu, B., & Spyropoulos, A. C. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.02.001 · Cited by 91
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 91
Self-citationAcute Clinical Care for Transgender Patients: A Review
Rosendale, N., Goldman, S., Ortiz, G. M., & Haber, L. A. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.4179 · Cited by 91
Kawashima, H., Watanabe, Y., Hioki, H., Kozuma, K., Kataoka, A., Nakashima, M., Nagura, F., Nara, Y., Yashima, F., Tada, N., et al. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.013 · Cited by 90
Chao, T.-F., Liu, C.-J., Chen, S.-J., Wang, K.-L., Lin, Y.-J., Chang, S.-L., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Wu, T.-J., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.667865 · Cited by 81
Schein, J. R., White, C. M., Nelson, W. W., Kluger, J., Mearns, E. S., & Coleman, C. I. (2016) · Thrombosis Journal · doi:10.1186/s12959-016-0088-y · Cited by 89
Migraine with visual aura is a risk factor for incident atrial fibrillation: A cohort study
Sen, S., Androulakis, X. M., Duda, V., Alonso, Á., Chen, L. Y., Soliman, E. Z., Magnani, J. W., Trivedi, T., Merchant, A. T., Gottesman, R. F., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000006650 · Cited by 89
Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation
Lutsey, P. L., Norby, F. L., Ensrud, K. E., MacLehose, R. F., Diem, S. J., Chen, L. Y., & Alonso, Á. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5679 · Cited by 89
Silverio, A., Maio, M. D., Prota, C., Angelis, E. D., Radano, I., Citro, R., Carrizzo, A., Ciccarelli, M., Vecchione, C., Capodanno, D., et al. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz073 · Cited by 90
Sex-Related Differences of Acute Stroke Unit Care: Results From the Austrian Stroke Unit Registry
Gattringer, T., Ferrari, J., Knoflach, M., Seyfang, L., Horner, S., Niederkorn, K., Culea, V., Beitzke, M., Lang, W., Enzinger, C., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.004897 · Cited by 89
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review
Sankaranarayanan, R., Kirkwood, G., Dibb, K., & Garratt, C. J. (2013) · Cardiology Research and Practice · doi:10.1155/2013/976976 · Cited by 78
Smith, J. G., Wieloch, M., Koul, S. M., Braun, O. Ö., Lumsden, J., Rydell, E., Öhman, J. N., Scherstén, F., Svensson, P. J., & van der Pals, J. (2012) · EuroIntervention · doi:10.4244/eijv8i6a105 · Cited by 89
Szymański, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., Szymańska, A., & Opolski, G. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.08.049 · Cited by 90
Self-citationHow to use D-dimer in acute cardiovascular care
Giannitsis, E., Mair, J. M., Christersson, C., Siegbahn, A. G., Huber, K., Jaffe, A. S., Peacock, W. F., Plebani, M., Thygesen, K. A., Möckel, M., et al. (2015) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872615610870 · Cited by 89
Königsbrügge, O., Posch, F., Antlanger, M., Kovařík, J., Klauser‐Braun, R., Kletzmayr, J., Schmaldienst, S., Auinger, M., Zuntner, G., Lorenz, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169400 · Cited by 91
Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation
Law, S. W. Y., Lau, W. C. Y., Wong, I. C. K., Lip, G. Y. H., Mok, M. T. C., Siu, C., & Chan, E. W. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.066 · Cited by 89
Self-citationGoldenthal, I. L., Sciacca, R. R., Riga, T. C., Henry, S. B., Baumeister, M., BIVIANO, A. B., Dizon, J. M., Wang, D., Wang, K. C., Whang, W., et al. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14160 · Cited by 88
Atrial Fibrillation Burden Signature and Near-Term Prediction of Stroke: A Machine Learning Analysis
Han, L., Askari, M., Altman, R. B., Schmitt, S. K., Fan, J., Bentley, J., Narayan, S. M., & Turakhia, M. P. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005595 · Cited by 88
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation
Lópes, R. D., Granger, C. B., WOJDYLA, D. M., McIntyre, W. F., Alings, M., Mani, T., Ramasundarahettige, C. F., Rivard, L., Atar, D., Birnie, D. H., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.002 · Cited by 88
Sandhu, R. K., Bakal, J. A., Ezekowitz, J. A., & McAlister, F. A. (2011) · Heart · doi:10.1136/heartjnl-2011-300901 · Cited by 88
Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project
Banerjee, A., Taillandier, S., Olesen, J. B., Lane, D. A., Lallemand, B., Lip, G. Y. H., & Fauchier, L. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.118 · Cited by 87
Self-citationOvervad, T. F., Skjøth, F., Lip, G. Y. H., Lane, D. A., Albertsen, I. E., Rasmussen, L. H., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009371 · Cited by 87
Self-citationChao, T., Liu, C., Tuan, T., Chen, S., Wang, K.-L., Lin, Y., Chang, S., Lo, L., Hu, Y., Chen, T., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.08.017 · Cited by 88
Hanon, O., Assayag, P., Belmin, J., Collet, J., Émeriau, J. P., Fauchier, L., Forette, F., Friocourt, P., Gentric, A., Leclercq, C., et al. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.04.001 · Cited by 89
Guo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 87
Self-citationLip, G. Y. H. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-01-0038 · Cited by 87
Self-citationKido, K., & Ngorsuraches, S. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018796604 · Cited by 86
Systemic embolism in amyloid transthyretin cardiomyopathy
Vilches, S., Fontana, M., González-López, E., Mitrani, L. R., Saturi, G., Renju, M., Griffin, J. M., Caponetti, A. G., Gnanasampanthan, S., Santos, J. D. L., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2566 · Cited by 86
Yoon, Y. E., Oh, I., Kim, S., Park, K.-H., Kim, S. H., Park, J., Kim, J.-E., Lee, S., Kim, H., Kim, Y.-J., et al. (2015) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.01.017 · Cited by 87
Weijs, B., Pisters, R., Haest, R. J. P., Kragten, J. A., Joosen, I. A., Versteylen, M. O., Timmermans, C. C., Pison, L., Blaauw, Y., Hofstra, L., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2012.08.013 · Cited by 86
Self-citationZhu, W., Xiong, Q., & Hong, K. (2015) · Texas Heart Institute Journal · doi:10.14503/thij-14-4353 · Cited by 88
İpek, G., Onuk, T., Karataş, M. B., Güngör, B., Ösken, A., Keskin, M., Öz, A., Tanık, O., Hayıroğlu, M. İ., Yılmaz, H. Y., et al. (2015) · Angiology · doi:10.1177/0003319715622844 · Cited by 86
Park, C. S., Choi, E., Kim, H. M., Lee, S., Cha, M., & Oh, S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.12.036 · Cited by 88
Clua‐Espuny, J. L., Lechuga-Durán, Í., Bosch, R., Roso‐Llorach, A., Panisello-Tafalla, A., Lucas-Noll, J., López, C., Queralt-Tomas, L., Giménez-García, E., González-Rojas, N., et al. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2013.03.006 · Cited by 86
Cullen, M. W., Kim, S., Piccini, J. P., Ansell, J., Fonarow, G. C., Hylek, E. M., Singer, D. E., Mahaffey, K. W., Kowey, P. R., Thomas, L. E., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000127 · Cited by 86
Alonso, A., Roetker, N. S., Soliman, E. Z., Chen, L. Y., Greenland, P., & Heckbert, S. R. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003077 · Cited by 81
Left atrial size and risk of stroke in patients in sinus rhythm: A systematic review
Overvad, T. F., Nielsen, P. B., Larsen, T. B., & Søgaard, P. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-12-0923 · Cited by 72
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial
Eisen, A., Ruff, C. T., Braunwald, E., Nordio, F., Corbalán, R., Dalby, A., Dorobantu, M., Mercuri, M., Lanz, H., Rutman, H., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003735 · Cited by 82
Frangieh, A. H., Alibegovic, J., Templin, C., Gaemperli, O., Obeid, S. N., Manka, R., Holy, E. W., Maier, W., Lüscher, T. F., & Binder, R. K. (2016) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.26805 · Cited by 85
Stone, D. L., Byrne, T., & Pershad, A. (2015) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.25065 · Cited by 84
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.